Minerva Endocrinology is a quarterly international, peer-reviewed scientific Journal on endocrine system diseases,
founded in 1976. It is indexed in EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SCIE), Scopus, and has
an Impact Factor of 2.184.
The journal encompasses all emerging areas in the field of Endocrinology and Metabolism, from research works on
endocrine system diseases, to basic clinical research, including meta-analysis, and the expectation is that of further
increasing the journal’s impact and contribution rate by increasing the number of invited reviews and special issues
on topics of current interest.
The aim is to provide a reliable forum for scientific communication among professionals while influencing the practice
of clinicians, researchers, industries at an international level and providing its readers with papers of the highest quality
thanks to a fast and thorough peer review process, careful editorial work as well as open access options.
Minerva Endocrinology welcomes articles on a wide variety of topics related to endocrinology, which may be submitted
in the form of editorials, original articles, review articles, special articles, letters to the Editor and guidelines